eXoZymes, Inc. (EXOZ) - Cash Flow Conversion Efficiency
Based on the latest financial reports, eXoZymes, Inc. (EXOZ) has a cash flow conversion efficiency ratio of -0.345x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.86 Million) by net assets ($5.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
eXoZymes, Inc. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how eXoZymes, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read eXoZymes, Inc. debt and liabilities for a breakdown of total debt and financial obligations.
eXoZymes, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of eXoZymes, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Les Docks des Pétroles d'Ambès -SA
PA:DPAM
|
0.034x |
|
ESTec Corporation
KQ:069510
|
0.036x |
|
APCB Inc
TW:6108
|
0.037x |
|
Envirosuite Ltd
AU:EVS
|
-0.033x |
|
Q.S.I Co. LTD
KQ:066310
|
0.001x |
|
ESTsoft Corp
KQ:047560
|
-0.074x |
|
Strix Group Plc
F:SG9
|
N/A |
|
Seanergy Maritime Holdings Corp
F:RHSR
|
0.037x |
Annual Cash Flow Conversion Efficiency for eXoZymes, Inc. (2021–2024)
The table below shows the annual cash flow conversion efficiency of eXoZymes, Inc. from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see eXoZymes, Inc. market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $10.42 Million | $-8.51 Million | -0.816x | -126.56% |
| 2023-12-31 | $-384.32K | $-1.18 Million | 3.073x | +435.48% |
| 2022-12-31 | $1.37 Million | $-1.26 Million | -0.916x | +30.90% |
| 2021-12-31 | $1.20 Million | $-1.59 Million | -1.325x | -- |
About eXoZymes, Inc.
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, Califor… Read more